 |  | Antibiotic & Chemotherapy
Roger G Finch FRCP, FRCPath, FFPM, Professor of Infectious Diseases, Division of Microbiology and Infectious Disease, Department of Clinical Laboratory Sciences, University of Nottingham and the Nottingham City Hospital NHS Trust, Nottingham, UK
David Greenwood BSc, PhD, DSc, FRCPath, Emeritus Professor of Antimicrobial Science, University of Nottingham Medical School, Nottingham, UK
S. Ragnar Norrby , Department of Infectious Diseases, Lund University Hospital, Lund, Sweden
Richard J Whitley MD, Loeb Eminent Scholar Chair in Pediatrics, Department of Pediatrics, The University of Alabama at Birmingham, The Children's Hospital, Birmingham, AL
Churchill Livingstone
|
Oncology
Roger G Finch FRCP, FRCPath, FFPM, Professor of Infectious Diseases, Division of Microbiology and Infectious Disease, Department of Clinical Laboratory Sciences, University of Nottingham and the Nottingham City Hospital NHS Trust, Nottingham, UK
David Greenwood BSc, PhD, DSc, FRCPath, Emeritus Professor of Antimicrobial Science, University of Nottingham Medical School, Nottingham, UK
S. Ragnar Norrby , Department of Infectious Diseases, Lund University Hospital, Lund, Sweden
Richard J Whitley MD, Loeb Eminent Scholar Chair in Pediatrics, Department of Pediatrics, The University of Alabama at Birmingham, The Children's Hospital, Birmingham, AL
Antibiotic and Chemotherapy, 8 th edition , is a comprehensive textbook that offers a globally-relevant account of the properties of all types of antimicrobial agent that are used in human medicine, and provides authoritative guidance on the principles and practice of antimicrobial chemotherapy.
The increasing problem of multi-drug resistance and the wide range of new antiviral therapies now available for the treatment of HIV and other viral infections are just two of the new areas discussed in this comprehensive and detailed new edition. In addition to full coverage of every commonly used antibiotic agent, there are extensive chapters on all antiviral, antiprotozoan and anthelminthic agents.
Completely revised throughout, with contributions from over 60 experts in infections disease / medical microbiology worldwide, the new edition of this classic text should answer all your questions on the treatment of infectious organisms.
REVIEWS OF THE PREVIOUS EDITION
- " . . . an absorbing, well written book, covering all aspects of antibiotic usage. I am sure it will make an invaluable addition to the shelf of any practising clinician who prescribes antibiotics." - Journal of Antimicrobial Chemotherapy
- " . . . clearly written, easy to refer to and remains an essential part of the library of every medical microbiology department. The latest edition is a fine achievement of scholarship and yet remains a help to the perplexed practitioner." - Journal of Infection
- "This book is a 'must' for all hospital pharmacy departments, infectious disease units and departments of medical microbiology." - Br J Hosp Med
- "Clearly written, easy to refer to and remains an essential part of the library of every medical microbiology department. The latest edition is a fine achievement of scholarship and yet remains a help to the perplexed practitioner." - Journal of Infection
Features
- Unique 3-part structure makes it easy to locate the information you need on a specific treatment or infection
- Part I covers general aspects of treatment - these chapters will be completely rewritten to be globally relevant
- Part II reviews every agent, giving antimicrobial activity, pharmacokinetics, clinical use, available preparations
- Chapters in part II will be templated so that all contributors are writing to the same level of detail and covering the same points
- Part III deals with the treatment of particular infections, with full clinical management details
- Clinical strategies for resistance control to be included where relevant
- Future therapeutic developments to be identified in each treatment area
What's New
- Huge new chapters on the new antiviral agents, particularly the antiretroviral agents used to treat HIV infection
- All new antimicrobial agents reviewed in detail
- Pharmacokinetic sections will be more clinically relevant, less theoretical
- detailed review of the new antifungal therapies (voriconazole, liposomal amphotericin B)
- Specific tables added on major drug interactions, placental transfer, concentrations of agents in breast milk.
- New sections on liver failure, drug development and licensing, implications of xenotransplantation
- Quinolone chapter greatly expanded to cover the wider spectrum of activity of the newer agents
- Lots more on the new antimalarial combination therapies
- Cross-referencing to key web-sites (e.g. CDC website) to direct the reader to the source of the most up-to-date information on treatment, drug resistance, etc
|
Table of Contents
|
|
|
|
|
 |  |
Roger G Finch FRCP FRCPath FFPM Professor of Infectious Diseases Division of Microbiology and Infectious Disease Department of Clinical Laboratory Sciences University of Nottingham and the Nottingham City Hospital NHS Trust Nottingham UK
br David Greenwood BSc PhD DSc FRCPath Emeritus Professor of Antimicrobial Science University of Nottingham Medical School Nottingham UK
br S Ragnar Norrby Department of Infectious Diseases Lund University Hospital Lund Sweden
br Richard J Whitley MD Loeb Eminent Scholar Chair in Pediatrics Department of Pediatrics The University of Alabama at Birmingham The Childrens Hospital Birmingham AL
Antibiotic Chemotherapy |
| |